FI
DCPH

Fosun International’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Fosun International’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-69,057
Closed -$2.34M – 252
2019
Q3 		$2.34M Sell
69,057
-58,980
-46% -$1.75M 0.26% 54
2019
Q2 		$2.89M Hold
128,037
– – 0.19% 82
2019
Q1 		$2.97M Hold
128,037
– – 0.19% 74
2018
Q4 		$2.69M Hold
128,037
– – 0.16% 70
2018
Q3 		$4.96M Buy
+128,037
New +$4.73M 0.24% 52

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fosun International's DCPH Position: Q4 2019 in Review

Fosun International sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2019, closing a stake of 69,057 shares — an estimated $2.34M sold.

Fosun International first reported a position in DCPH in Q3 2018 and held it in 5 quarters. The position peaked at $4.96M in Q3 2018. 153 funds tracked by Wall St. Rank hold DCPH as of Q4 2019.

  • Fosun International reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Fosun International sold 69,057 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $2.34M.
  • Fosun International first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2018 and held it in 5 quarters.
  • Fosun International's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $4.96M in Q3 2018.
  • 153 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Fosun International's 13F filing for Q4 2019, filed 18 Feb 2020.